Inhaled beta-2 agonists and steroids. Present state and future perspectives.
Clauzel
A M
AM
CHR Montpellier, France.
D000042:Absorption; D000280:Administration, Inhalation; D000287:Administration, Topical; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001249:Asthma / Q000188:drug therapy*; D004304:Dosage Forms; D005544:Forecasting; D005938:Glucocorticoids; D006801:Humans; D014018:Tissue Distribution
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D004304:Dosage Forms; D005938:Glucocorticoids